Hematology Research Program
The Hematology Research Program (HRP) has brought innovative therapies to patients with blood diseases including the development of less toxic therapies, new methods of delivering medications, and evaluation of novel drug combinations. Many of these therapies have both extended the life expectancy and improved the quality of life of patients participating in our clinical trials.
The key areas of research at HRP include: understanding how normal blood cells and stem cells become diseased or evolve into cancers, the development of safer and more effective treatments, and diagnostic tests for blood diseases. Through the Program’s clinical trials, patients have the opportunity to participate in studies that provide access to leading edge treatments that are unavailable through standard care.
For more information, Click here.